Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation

References

• Alam MI , Beg S , Samad A , et al . (2010). Strategy for effective brain drug delivery. Eur J Pharm Sci 40:385–403.
   PubMed Web of Science ®Google Scholar
• Alsarra IA , Hamed AY , Alanazi FK , et al . (2010). Vesicular systems for intranasal drug delivery. Drug delivery to the central nervous system. Springer.
   Google Scholar
• Audinot V , Mailliet F , Lahaye-Brasseur C , et al . (2003). New selective ligands of human cloned melatonin MT1 and MT2 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 367:553–61.
   Google Scholar
• Battaglia L , Gallarate M. (2012). Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv 9:497–508.
   PubMed Web of Science ®Google Scholar
• Behl C , Pimplaskar H , Sileno A , et al . (1998). Optimization of systemic nasal drug delivery with pharmaceutical excipients. Adv Drug Deliv Rev 29:117–33.
   PubMed Web of Science ®Google Scholar
• Cabana A , Aï T-Kadi A , Juhász J. (1997). Study of the gelation process of polyethylene oxide a–polypropylene oxide b–polyethylene oxide a copolymer (Poloxamer 407) aqueous solutions. J Colloid Interf Sci 190:307–12.
   PubMed Web of Science ®Google Scholar
• Dehouck B , Fenart L , Dehouck M-P , et al . (1997). A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol 138:877–89.
   PubMed Web of Science ®Google Scholar
• Derringer G. (1980). Simultaneous optimization of several response variables. J Qual Technol 12:214–9.
   Web of Science ®Google Scholar
• Desai P , Jain N , Sharma R , et al . (2001). Effect of additives on the micellization of PEO/PPO/PEO block copolymer F127 in aqueous solution. Colloids Surf A Physicochem Eng Aspects 178:57–69.
   Web of Science ®Google Scholar
• Dhuria SV , Hanson LR , Frey WH. (2010). Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99:1654–73.
   PubMed Web of Science ®Google Scholar
• Dias RJ , Mali KK , Shinde JV , et al . (2010). Formulation and evaluation of thermoreversible mucoadhesive nasal gels of metoclopramide hydrochloride. Lat Am J Pharm 29:354–61.
   Web of Science ®Google Scholar
• Esposito E , Fantin M , Marti M , et al . (2008). Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm Res 25:1521–30.
   PubMed Web of Science ®Google Scholar
• Fatouh AM , Elshafeey AH , Abdelbary A. (2017). Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics. Drug Des Devel Ther 11:1815–25.
   PubMed Web of Science ®Google Scholar
• Gastaldi L , Battaglia L , Peira E , et al . (2014). Solid lipid nanoparticles as vehicles of drugs to the brain: Current state of the art. Eur J Pharm Biopharm 87:433–44.
   PubMed Web of Science ®Google Scholar
• Gilbert JC , Richardson JL , Davies MC , et al . (1987). The effect of solutes and polymers on the gelation properties of pluronic F-127 solutions for controlled drug delivery. J Control Release 5:113–8.
   Google Scholar
• Haque S , Md S , Sahni JK , et al . (2014). Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression. J Psychiatric Res 48:1–12.
   PubMed Web of Science ®Google Scholar
• Huffman AS , Afrassiabi A , Dong LC. (1986). Thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions. J Control Release 4:213–22.
   Google Scholar
• Illum L , Farraj NF , Davis SS. (1994). Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res 11:1186–9.
   PubMed Web of Science ®Google Scholar
• Kozlovskaya L , Abou-Kaoud M , Stepensky D. (2014). Quantitative analysis of drug delivery to the brain via nasal route. J Control Release 189:133–40.
   PubMed Web of Science ®Google Scholar
• Kreuter J. (2005). Application of nanoparticles for the delivery of drugs to the brain. Int Congress Ser 1277:85–94. doi: https://doi.org/10.1016/j.ics.2005.02.014 Elsevier.
   Google Scholar
• Lale A , Mason J , Jones N. (1998). Mucociliary transport and its assessment: a review. Clin Otolaryngol 23:388–96.
   PubMed Web of Science ®Google Scholar
• Lasa-Saracibar B , Estella-Hermoso De Mendoza A , et al . (2012). Lipid nanoparticles for cancer therapy: state of the art and future prospects. Expert Opin Drug Deliv 9:1245–61.
   PubMed Web of Science ®Google Scholar
• Matthew JE , Nazario YL , Roberts SC , et al . (2002). Effect of mammalian cell culture medium on the gelation properties of Pluronic® F127. Biomaterials 23:4615–9.
   PubMed Web of Science ®Google Scholar
• Millan MJ , Gobert A , Lejeune F , et al . (2003). The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther 306:954–64.
   PubMed Web of Science ®Google Scholar
• Moghimi SM , Porter C , Muir I , et al . (1991). Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem Biophys Res Commun 177:861–6.
   PubMed Web of Science ®Google Scholar
• Nanjawade BK , Manvi F , Manjappa A. (2007). RETRACTED: In situ-forming hydrogels for sustained ophthalmic drug delivery. J Control Release 122:119–34.
   PubMed Web of Science ®Google Scholar
• Ruel-Gariepy E , Leroux JC. (2004). In situ-forming hydrogels–review of temperature-sensitive systems. Eur J Pharm Biopharm 58:409–26.
   PubMed Web of Science ®Google Scholar
• Schmolka IR. (1972). Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res 6:571–82.
   PubMed Web of Science ®Google Scholar
• Sharma PK , Reilly MJ , Jones DN , et al . (2008). The effect of pharmaceuticals on the nanoscale structure of PEO-PPO-PEO micelles. Colloids Surf B Biointerf 61:53–60.
   PubMed Web of Science ®Google Scholar
• Soane R , Hinchcliffe M , Davis S , et al . (2001). Clearance characteristics of chitosan based formulations in the sheep nasal cavity. Int J Pharm 217:183–91.
   PubMed Web of Science ®Google Scholar
• Tsai M-J , Wu P-C , Huang Y-B , et al . (2012). Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm 423:461–70.
   PubMed Web of Science ®Google Scholar
• Tung I-C. (1994). Rheological behavior of poloxamer 407 aqueous solutions during sol-gel and dehydration processes. Int J Pharm 107:85–90.
   Web of Science ®Google Scholar
• Ufada C. (2005). Guidance for industry. Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers.
   Google Scholar
• Vadnere M , Amidon G , Lindenbaum S , et al . (1984). Thermodynamic studies on the gel-sol transition of some pluronic polyols. Int J Pharm 22:207–18.
   Web of Science ®Google Scholar
• Watts P , Smith A. (2009). PecSys: in situ gelling system for optimised nasal drug delivery.
   Google Scholar
• Yous S , Andrieux J , Howell H , et al . (1992). Novel naphthalenic ligands with high affinity for the melatonin receptor. J Med Chem 35:1484–6.
   PubMed Web of Science ®Google Scholar
• Zaki NM , Awad GA , Mortada ND , et al . (2007). Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci 32:296–307.
   PubMed Web of Science ®Google Scholar
• Zupancic M , Guilleminault C. (2006). Agomelatine: a preliminary review of a new antidepressant. CNS Drugs 20:981–92.
   PubMed Web of Science ®Google Scholar